Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
HW

Hexiang Wang — 14 Patents

BEBeigene: 14 patents #3 of 41Top 8%
Beijing, CN: #1,921 of 27,914 inventorsTop 7%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Hexiang Wang has been granted 14 US patents while listed as an inventor at Beigene. The first was granted in 2016 and the most recent in October 2022. Hexiang Wang ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Hexiang Wang in Beijing, CN.

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11472788 Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases Yunhang Guo, Zhiwei Wang, Changyou Zhou 2022-10-18 $69,758,000
11202782 Treatment cancers using a combination comprising PARP inhibitors Lai-Xi Wang, Zhiyu Tang, Lusong Luo, Min Wei, Kang Li +4 more 2021-12-21 $86,031,000
10899763 Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof Xianzhao Kuang, Changyou Zhou 2021-01-26 $204,177,000
10882856 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases Yunhang Guo, Bo Ren, Zhiwei Wang, Guoliang Zhang, Changyou Zhou 2021-01-05 $149,657,000
10647714 5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases Guoliang Zhang, Yunhang Guo, Bo Ren, Zhiwei Wang, Changyou Zhou 2020-05-12 $96,094,000
10501467 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2019-12-10 $95,456,000
10457680 Process for preparing a PARP inhibitor, crystalline forms, and uses thereof Changyou Zhou, Bo Ren, Xianzhao Kuang 2019-10-29 $62,841,000
10280163 5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases Guoliang Zhang, Yunhang Guo, Bo Ren, Zhiwei Wang, Changyou Zhou 2019-05-07 $55,702,000
10112952 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2018-10-30 $59,054,000
9827226 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones Bo Ren, Changyou Zhou 2017-11-28 $29,091,000
9617273 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2017-04-11 $7,927,000
9393232 Substituted 5-(3,5-dimethylisoxazol-4-yl)indoline-2-ones Bo Ren, Changyou Zhou 2016-07-19 $3,106,000
9328111 Substituted cycloocta[5,6]pyrido[4,3,2-de]phthalazines as PARP inhibitors Changyou Zhou, Bo Ren 2016-05-03 $3,441,000
9260440 Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors Changyou Zhou, Bo Ren 2016-02-16